Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders

Journal of Neurochemistry

Volumn 126, Issue 2, 2013, Pages 165-182

  Penzes, Peter ^a   Buonanno, Andres ^b   Passafaro, Maria ^c,d   Sala, Carlo ^c,e   Sweet, Robert A ^f,g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d CNR   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g Education and Clinical Center   (United States)

Author keywords

Alzheimer's disease; autism; dendritic spine; dopamine; ErbB4; GABAergic interneuron

Indexed keywords

ACYLTRANSFERASE; AMYLOID BETA PROTEIN; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOPAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN LIKE 1; MEMBRANE PROTEIN; NEU DIFFERENTIATION FACTOR; NUCLEAR PROTEIN; OLIGOPHRENIN 1; PROTEIN DGCR8; PROTEIN TSPAN7; PROTEIN ZDHHC8; RHO FACTOR; SCAFFOLD PROTEIN; SHANK PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTISM; BRAIN CORTEX; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DENDRITIC SPINE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL DISEASE; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYNAPSE; SYNAPTIC CIRCUIT;

ALZHEIMER'S DISEASE; AUTISM; DENDRITIC SPINE; DOPAMINE; ERBB4; GABAERGIC INTERNEURON;

ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; NERVE NET; NERVOUS SYSTEM DISEASES; SYNAPSES;

EID: 84879956588     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12261     Document Type: Review

References (217)

1. Abidi F. E., Holinski-Feder E., Rittinger O., Kooy F., Lubs H. A., Stevenson R. E., and, Schwartz C. E., (2002) A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58. J. Med. Genet. 39, 430-433.
2. Akbarian S., and, Huang H. S., (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 52, 293-304.
3. Akbarian S., Kim J. J., Potkin S. G., Hagman J. O., Tafazzoli A., Bunney W. E. Jr, and, Jones E. G., (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266.
4. Alvarez V. A., and, Sabatini B. L., (2007) Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 79-97.
5. Andersson R. H., Johnston A., Herman P. A., Winzer-Serhan U. H., Karavanova I., Vullhorst D., Fisahn A,. and, Buonanno A., (2012) Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc. Natl Acad. Sci. USA 109, 13118-13123.
6. Arango C., Moreno C., Martínez S., Parellada M., Desco M., Moreno D., Fraguas D., Gogtay N., James A., and, Rapoport J., (2008) Longitudinal brain changes in early-onset psychosis. Schizophr. Bull. 34, 341-353.
7. Ayhan Y., Abazyan B., and, Nomura J., et al,. (2011) Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry 16, 293-306.
8. Bacanu S. A., Devlin B., Chowdari K. V., DeKosky S. T., Nimgaonkar V. L., and, Sweet R. A., (2005) Heritability of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 13, 624-627.
9. Baloyannis S. J., Costa V., Mauroudis I., Psaroulis D., Manolides S. L., and, Manolides L. S., (2007) Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy. Acta Otolaryngol. 127, 351-354.
10. Barros C. S., Calabrese B., Chamero P., Roberts A. J., Korzus E., Lloyd K., Stowers L., Mayford M., Halpain S., and, Müller U., (2009) Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl Acad. Sci. USA 106, 4507-4512.
11. Barta P. E., Pearlson G. D., Powers R. E., Richards S. S., and, Tune L. E., (1990) Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry 147, 1457-1462.
12. Bartos M., Vida I., and, Jonas P., (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 8, 45-56.
13. Bassani S., Cingolani L. A., Valnegri P., Folci A., Zapata J., Gianfelice A., Sala C., Goda Y., and, Passafaro M., (2012) The X-Linked Intellectual Disability Protein TSPAN7 Regulates Excitatory Synapse Development and AMPAR Trafficking. Neuron 73, 1143-1158.
14. Bean B. P., (2007) The action potential in mammalian central neurons. Nat. Rev. Neurosci. 8, 451-465.
15. Belforte J. E., Zsiros V., Sklar E. R., Jiang Z., Yu G., Li Y., Quinlan E. M., and, Nakazawa K., (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 76-83.
16. Bergeron R., and, Coyle J. T., (2012) NAAG, NMDA receptor and psychosis. Curr. Med. Chem. 19, 1360-1364.
17. Berkel S., Marshall C. R., Weiss B., et al,. (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489-491.
18. Bhat S. S., Ladd S., Grass F., Spence J. E., Brasington C. K., Simensen R. J., Schwartz C. E., Dupont B. R., Stevenson R. E., and, Srivastava A. K., (2008) Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism. Clin. Genet. 73, 94-96.
19. Bhat S., Dao D. T., Terrillion C. E., Arad M., Smith R. J., Soldatov N. M., and, Gould T. D., (2012) CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol. 99, 1-14.
20. Bittner T., Fuhrmann M., Burgold S., Ochs S. M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F. M., and, Herms J., (2010) Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 5, e15477.
21. Bockers T. M., Segger-Junius M., Iglauer P., Bockmann J., Gundelfinger E. D., Kreutz M. R., Richter D., Kindler S., and, Kreienkamp H. J., (2004) Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3′ untranslated region of Shank1 mRNA. Mol. Cell. Neurosci. 26, 182-190.
22. Bonaglia M. C., Giorda R., Borgatti R., Felisari G., Gagliardi C., Selicorni A., and, Zuffardi O., (2001) Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261-268.
23. Bozdagi O., Sakurai T., Papapetrou D., et al,. (2010) Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 1, 15.
24. Bruen P. D., McGeown W. J., Shanks M. F., and, Venneri A., (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 131, 2455-2463.
25. Buonanno A., (2010) The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res. Bull. 83, 122-131.
26. Buonanno A., and, Fischbach G. D., (2001) Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11, 287-296.
27. Burbach J. P., and, van der Zwaag B., (2009) Contact in the genetics of autism and schizophrenia. Trends Neurosci. 32, 69-72.
28. Cahill M. E., Xie Z., Day M., et al,. (2009) Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl Acad. Sci. USA 106, 13058-13063.
29. Carrie A., Jun L., Bienvenu T., et al,. (1999) A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 23, 25-31.
30. Casamassima F., Hay A. C., Benedetti A., Lattanzi L., Cassano G. B., and, Perlis R. H., (2010) L-type calcium channels and psychiatric disorders: A brief review. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 1373-1390.
31. Chattopadhyaya B., and, Cristo G. D., (2012) GABAergic circuit dysfunctions in neurodevelopmental disorders. Front. Psychiatry 3, 51.
32. Chen Y. J., Johnson M. A., Lieberman M. D., et al,. (2008) Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 6872-6883.
33. Chen Y., Hancock M. L., Role L. W., and, Talmage D. A., (2010) Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J. Neurosci. 30, 9199-9208.
34. Chu S. H., Roeder K., Ferrell R. E., Devlin B., DeMichele-Sweet M. A., Kamboh M. I., Lopez O. L., and, Sweet R. A., (2011) TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease. Neurobiol. Aging 32, 2328-2329.
35. Cobb S. R., Buhl E. H., Halasy K., Paulsen O., and, Somogyi P., (1995) Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378, 75-78.
36. Collins A. L., Ma D., Whitehead P. L., et al,. (2006) Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics 7, 167-174.
37. Dean B., Keriakous D., Scarr E., and, Thomas E. A., (2007) Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust. N. Z. J. Psychiatry 41, 308-320.
38. Delahaye A., Toutain A., Aboura A., Dupont C., Tabet A. C., Benzacken B., Elion J., Verloes A., Pipiras E., and, Drunat S., (2009) Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. Eur. J. Med. Genet. 52, 328-332.
39. DeMichele-Sweet M. A., Lopez O. L., and, Sweet R. A., (2011a) Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e1. Int. J. Alzheimers Dis. 2011, 926597.
40. DeMichele-Sweet M. A., Klei L., Devlin B., Ferrell R. E., Weamer E. A., Emanuel J. E., Lopez O. L., and, Sweet R. A., (2011b) No association of psychosis in Alzheimer disease with neurodegenerative pathway genes. Neurobiol. Aging 32, 555.e9-555.e11.
41. Demiralp T., Herrmann C. S., Erdal M. E., Ergenoglu T., Keskin Y. H., Ergen M., and, Beydagi H., (2007) DRD4 and DAT1 Polymorphisms Modulate Human Gamma Band Responses. Cereb. Cortex 17, 1007-1019.
42. Deo A. J., Cahill M. E., Li S., et al,. (2011) Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology. Neurobiol. Dis. 45, 796-803.
43. DiMaio S., Grizenko N., and, Joober R., (2003) Dopamine genes and attention-deficit hyperactivity disorder: a review. J. Psychiatry Neurosci. 28, 27-38.
44. Durand C. M., Betancur C., Boeckers T. M., et al,. (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25-27.
45. Emanuel J. E., Lopez O. L., Houck P. R., Becker J. T., Weamer E. A., DeMichele-Sweet M. A., Kuller L., and, Sweet R. A., (2011) Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am. J. Geriatr. Psychiatry 19, 160-168.
46. Engel A. K., and, Singer W., (2001) Temporal binding and the neural correlates of sensory awareness. Trends Cogn. Sci. 5, 16-25.
47. Fatemi S. H., Halt A. R., Stary J. M., Kanodia R., Schulz S. C., and, Realmuto G. R., (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805-810.
48. Fatemi S. H., Reutiman T. J., Folsom T. D., and, Thuras P. D., (2009) GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 39, 223-230.
49. Fazzari P., Paternain A. V., Valiente M., Pla R., Luján R., Lloyd K., Lerma J., Marín O., and, Rico B., (2010) Control of cortical GABA circuitry development by Nrg1 and ErbB4 signaling. Nature 464, 1376-1380.
50. Fetterolf F., and, Foster K. A., (2011) Regulation of long-term plasticity induction by the channel and C-terminal domains of GluN2 subunits. Mol. Neurobiol. 44, 71-82.
51. Fisahn A., Neddens J., Yan L., and, Buonanno A., (2009) Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb. Cortex 19, 612-618.
52. Fox I. J., and, Kornblum H. I., (2005) Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions. J. Neurosci. Res. 79, 584-597.
53. Franek K. J., Butler J., Johnson J., et al,. (2011) Deletion of the immunoglobulin domain of IL1RAPL1 results in nonsyndromic X-linked intellectual disability associated with behavioral problems and mild dysmorphism. Am. J. Med. Genet. A 155A, 1109-1114.
54. Franke B., Neale B. M., and, Faraone S. V., (2009) Genome-wide association studies in ADHD. Hum. Genet. 126, 13-50.
55. Fuchs E. C., Zivkovic A. R., Cunningham M. O., et al,. (2007) Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53, 591-604.
56. Gai X., Xie H. M., Perin J. C., et al,. (2012) Rare structural variation of synapse and neurotransmission genes in autism. Mol. Psychiatry 17, 402-411.
57. Garcia R. A., Vasudevan K., and, Buonanno A., (2000) The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl Acad. Sci. USA 97, 3596-3601.
58. Gasbarri A., Packard M. G., Campana E., and, Pacitti C., (1994) Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation in the rat. Brain Res. Bull. 33, 445-452.
59. Gasbarri A., Sulli A., and, Packard M. G., (1997) The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 21, 1-22.
60. Gauthier J., Spiegelman D., Piton A., et al,. (2009) Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 421-424.
61. Gerecke K. M., Wyss J. M., Karavanova I., Buonanno A., and, Carroll S. L., (2001) ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J. Comp. Neurol. 433, 86-100.
62. Gilman S. R., Iossifov I., Levy D., Ronemus M., Wigler M., and, Vitkup D., (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898-907.
63. Girirajan S., and, Eichler E. E,. (2010) Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet. 19, R176-R187.
64. Glantz L. A., and, Lewis D. A., (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65-73.
65. Gogolla N., Leblanc J. J., Quast K. B., Sudhof T. C., Fagiolini M., and, Hensch T. K., (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 1, 172-181.
66. Gonzalez-Burgos G., and, Lewis D. A., (2008) GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 34, 944-961.
67. Gonzalez-Burgos G., and, Lewis D. A., (2012) NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 38, 950-957.
68. Govek E. E., Newey S. E., Akerman C. J., Cross J. R., Van der Veken L., and, Van Aelst L., (2004) The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 7, 364-372.
69. Govindaiah G., Wang Y., and, Cox C. L., (2010) Dopamine enhances the excitability of somatosensory thalamocortical neurons. Neuroscience 170, 981-991.
70. Greenwood T. A., Lazzeroni L. C., Murray S. S., et al,. (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiat. 168, 930-946.
71. Greenwood T. A., Light G. A., Swerdlow N. R., Radant A. D., and, Braff D. L., (2012) Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 7, e29630.
72. Grutzendler J., Helmin K., Tsai J., and, Gan W. B., (2007) Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1097, 30-39.
73. Guilmatre A., Dubourg C., Mosca A. L., et al,. (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66, 947-956.
74. Guptill J. T., Booker A. B., Gibbs T. T., Kemper T. L., Bauman M. L., and, Blatt G. J., (2007) [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study. J. Autism Dev. Disord. 37, 911-920.
75. Hall J., Whalley H. C., Job D. E., et al,. (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9, 1477-1478.
76. Harrison P. J., and, Weinberger D. R,. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40-68; image 45.
77. Hayashi-Takagi A., Takaki M., Graziane N., et al,. (2010) Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327-332.
78. Herrmann C. S., and, Demiralp T., (2005) Human EEG gamma oscillations in neuropsychiatric disorders. Clin. Neurophysiol. 116, 2719-2733.
79. Hill J. J., Hashimoto T., and, Lewis D. A., (2006) Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 11, 557-566.
80. Hollingworth P., Hamshere M. L., Holmans P. A., et al,. (2007) Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 841-848.
81. Hollingworth P., Sweet R., Sims R., et al,. (2011) Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol. Psychiatry 17, 1316-1327.
82. Holtmaat A., and, Svoboda K., (2009) Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. 10, 647-658.
83. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and, Malinow R., (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843.
84. Huang Y. Z., Won S., Ali D. W., et al,. (2000) Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26, 443-455.
85. Hung A. Y., Futai K., Sala C., et al,. (2008) Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28, 1697-1708.
86. Ide M., and, Lewis D. A., (2010) Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits. Biol. Psychiatry 68, 25-32.
87. Janssen M. J., Leiva-Salcedo E., and, Buonanno A., (2012) Neuregulin directly decreases voltage-gated sodium current in hippocampal ErbB4-expressing interneurons. J. Neurosci. 32, 13889-13895.
88. Jay T. M., (2003) Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 69, 375-390.
89. Kalus P., Bondzio J., Federspiel A., Muller T. J., and, Zuschratter W., (2002) Cell-type specific alterations of cortical interneurons in schizophrenic patients. NeuroReport 13, 713-717.
90. Kantrowitz J. T., and, Javitt D. C., (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108-121.
91. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., and, Roberts R. C., (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 497, 436-450.
92. Kirov G., Pocklington A. J., Holmans P., et al,. (2012) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153.
93. Koffie R. M., Meyer-Luehmann M., Hashimoto T., et al,. (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl Acad. Sci. USA 106, 4012-4017.
94. Koffie R. M., Hyman B. T., and, Spires-Jones T. L., (2011) Alzheimer's disease: synapses gone cold. Mol. Neurodegener. 6, 63.
95. Kolomeets N. S., Orlovskaya D. D., Rachmanova V. I., and, Uranova N. A., (2005) Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 57, 47-55.
96. Kolomeets N. S., Orlovskaya D. D., and, Uranova N. A., (2007) Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse 61, 615-621.
97. Kotrla K. J., Chacko R. C., Harper R. G., Jhingran S., and, Doody R., (1995) SPECT findings on psychosis in Alzheimer's disease. Am. J. Psychiatry 152, 1470-1475.
98. Kvajo M., McKellar H., Arguello P. A., Drew L. J., Moore H., MacDermott A. B., Karayiorgou M., and, Gogos J. A., (2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl Acad. Sci. USA 105, 7076-7081.
99. Kwon J. S., O'Donnell B. F., Wallenstein G. V., Greene R. W., Hirayasu Y., Nestor P. G., Hasselmo M. E., Potts G. F., Shenton M. E., and, McCarley R. W., (1999) Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry 56, 1001-1005.
100. Kwon O. B., Paredes D., Gonzalez C. M., Neddens J., Hernandez L., Vullhorst D., and, Buonanno A., (2008) Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc. Natl Acad. Sci. USA 105, 15587-15592.
101. Lai C., and, Lemke G., (1991) An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6, 691-704.
102. Laumonnier F., Cuthbert P. C., and, Grant S. G., (2007) The role of neuronal complexes in human X-linked brain diseases. Am. J. Hum. Genet. 80, 205-220.
103. Law A. J., Weickert C. S., Hyde T. M., Kleinman J. E., and, Harrison P. J., (2004) Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am. J. Psychiatry 161, 1848-1855.
104. Law A. J., Kleinman J. E., Weinberger D. R., and, Weickert C. S., (2007) Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16, 129-141.
105. Lawrence J. J, Saraga F., Churchill J. F., Statland J. M., Travis K. E., Skinner F. K., and, McBain C. J., (2006) Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons. J. Neurosci. 26, 12325-12338.
106. Lewis D. A., and, Gonzalez-Burgos G., (2008) Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33, 141-165.
107. Lewis D. A., and, Levitt P., (2002) Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409-432.
108. Lewis D. A., Hashimoto T., and, Volk D. W., (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312-324.
109. Li B., Woo R. S., Mei L., and, Malinow R., (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583-597.
110. Li K. X., Lu Y. M., Xu Z. H., et al,. (2012) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat. Neurosci. 15, 267-273.
111. Lipska B. K., Peters T., Hyde T. M., et al,. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15, 1245-1258.
112. Lisman J. E., and, Grace A. A., (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703-713.
113. Lisman J. E., Coyle J. T., Green R. W., Javitt D. C., Benes F. M., Heckers S., and, Grace A. A., (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242.
114. Longart M., Chatani-Hinze M., Gonzalez C. M., Vullhorst D., and, Buonanno A., (2007) Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons. Brain Res. Bull. 73, 210-219.
115. Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E., and, Rogers J., (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862.
116. Ma X. M., Kiraly D. D., Gaier E. D., Wang Y., Kim E. J., Levine E. S., Eipper B. A., and, Mains R. E., (2008) Kalirin-7 is required for synaptic structure and function. J. Neurosci. 28, 12368-12382.
117. Matzner O., and, Devor M., (1992) Na+ conductance and the threshold for repetitive neuronal firing. Brain Res. 597, 92-98.
118. Mega M. S., Lee L., Dinov I. D., Mishkin F., Toga A. W., and, Cummings J. L., (2000) Cerebral correlates of psychotic symptoms in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 69, 167-171.
119. Mei L., and, Xiong W. C., (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452.
120. Meier S., Demirakca T., Brusniak W., et al,. (2012) SCN1A affects brain structure and the neural activity of the aging brain. Biol. Psychiatry 72, 677-683.
121. Mentis M. J., Weinstein E. A., Horwitz B., McIntosh A. R., Pietrini P., Alexander G. E., Furey M., and, Murphy D. G., (1995) Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biol. Psychiatry 38, 438-449.
122. Meyer U., and, Feldon J., (2009) Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav. Brain Res. 204, 322-334.
123. Milescu L. S., Yamanishi T., Ptak K., and, Smith J. C., (2010) Kinetic properties and functional dynamics of sodium channels during repetitive spiking in a slow pacemaker neuron. J. Neurosci. 30, 12113-12127.
124. Millar J. K., Christie S., and, Porteous D. J., (2003) Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311, 1019-1025.
125. Moessner R., Marshall C. R., Sutcliffe J. S., et al,. (2007) Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81, 1289-1297.
126. Mohn A. R., Gainetdinov R. R., Caron M. G., and, Koller B. H., (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436.
127. Moran E. K., Becker J. A., Satlin A., Lyoo I. K., Fischman A. J., and, Johnson K. A., (2008) Psychosis of Alzheimer's disease: Gender differences in regional perfusion. Neurobiol. Aging 29, 1218-1225.
128. Mukai J., Dhilla A., Drew L. J., Stark K. L., Cao L., MacDermott A. B., Karayiorgou M., and, Gogos J. A., (2008) Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302-1310.
129. Munafo M. R., Thiselton D. L., Clark T. G., and, Flint J., (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 11, 539-546.
130. Munafo M. R., Attwood A. S., and, Flint J., (2008) Neuregulin 1 genotype and schizophrenia. Schizophr. Bull. 34, 9-12.
131. Murray M. M., Bernstein S. L., Nyugen V., Condron M. M., Teplow D. B., and, Bowers M. T., (2009) Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J. Am. Chem. Soc. 131, 6316-6317.
132. Murray P. S., Kirkwood C. M., Gray M. C., et al,. (2012) beta-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol. Aging 33, 2807-2816.
133. Murray P. S., Kirkwood C. M., Ikonomovic M. D., Fish K. N., and, Sweet R. A., (2013) Tau phosphorylation is exaggerated in Alzheimer disease with psychosis. Am. J. Geriatr. Psychiatry. 21, S80-S81.
134. Nadif Kasri N., and, Van Aelst L., (2008) Rho-linked genes and neurological disorders. Pflugers Arch. 455, 787-797.
135. Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P., and, Buxbaum J. D., (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571-1577.
136. Neddens J., and, Buonanno A., (2009) Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20, 724-744.
137. Neddens J., and, Buonanno A., (2011) Expression of the neuregulin receptor ErbB4 in the brain of the rhesus monkey (Macaca mulatta). PLoS ONE 6, e27337.
138. Neddens J., Fish K. N., Tricoire L., Vullhorst D., Shamir A., Chung W., Lewis D. A., McBain C. J., and, Buonanno A., (2011) Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol. Psychiatry 70, 636-645.
139. Nicodemus K. K., Law A. J., Radulescu E., et al,. (2010) Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch. Gen. Psychiatry 67, 991-1001.
140. Oblak A. L., Gibbs T. T., and, Blatt G. J., (2010) Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J. Neurochem. 114, 1414-1423.
141. O'Roak B. J., and, State M. W., (2008) Autism genetics: strategies, challenges, and opportunities. Autism. Res. 1, 4-17.
142. Owen M. J., Craddock N., and, O'Donovan M. C., (2005) Schizophrenia: genes at last? Trends Genet. 21, 518-525.
143. Pavlowsky A., Gianfelice A., Pallotto M., et al,. (2010) A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Curr. Biol. 20, 103-115.
144. Peça J., Feliciano C., Ting J. T., Wang W., Wells M. F., Venkatraman T. N., Lascola C. D., Fu Z., and, Feng G., (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437-442.
145. Penzes P., and, Jones K. A., (2008) Dendritic spine dynamics-a key role for kalirin-7. Trends Neurosci. 31, 419-427.
146. Penzes P., Cahill M. E., Jones K. A., and, Srivastava D. P., (2008) Convergent CaMK and RacGEF signals control dendritic structure and function. Trends Cell Biol. 18, 405-413.
147. Penzes P., Cahill M. E., Jones K. A., VanLeeuwen J. E., and, Woolfrey K. M., (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285-293.
148. Pinto D., Pagnamenta A. T., Klei L., et al,. (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368-372.
149. Piton A., Michaud J. L., Peng H., et al,. (2008) Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 17, 3965-3974.
150. Poot M., van der Smagt J. J., Brilstra E. H., and, Bourgeron T., (2011) Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenet. Genome Res. 135, 228-240.
151. Powell A. D., Gill K. K., Saintot P. P., Jiruska P., Chelly J., Billuart P., and, Jefferys J. G., (2012) Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation. J. Physiol. 590, 763-776.
152. Rakic P., Bourgeois J. P., Eckenhoff M. F., Zecevic N., and, Goldman-Rakic P. S., (1986) Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 232, 232-235.
153. Rapoport J. L., Addington A. M., Frangou S., and, Psych M. R., (2005) (2005) The neurodevelopmental model of schizophrenia: update. Mol. Psychiatry 10, 434-449.
154. Rauch A., Hoyer J., Guth S., et al,. (2006) Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet. A 140, 2063-2074.
155. Ropacki S. A., and, Jeste D. V., (2005) Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry 162, 2022-2030.
156. Ropers H. H., and, Hamel B. C., (2005) X-linked mental retardation. Nat. Rev. Genet. 6, 46-57.
157. Rosen A. M., and, Stevens B., (2010) The role of the classical complement cascade in synapse loss during development and glaucoma. Adv. Exp. Med. Biol. 703, 75-93.
158. Sato D., Lionel A. C., Leblond C. S., et al,. (2012) SHANK1 Deletions in Males with Autism Spectrum Disorder. Am. J. Hum. Genet. 90, 879-887.
159. Scheff S. W., and, Price D. A., (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 24, 1029-1046.
160. Schmeisser M. J., Ey E., Wegener S., et al,. (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256-260.
161. Schumacher J., Laje G., Abou Jamra R., et al,. (2009) The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 18, 2719-2727.
162. Seeman P., (2009) Glutamate and dopamine components in schizophrenia. J. Psychiatry Neurosci. 34, 143-149.
163. Selemon L. D., and, Goldman-Rakic P. S., (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17-25.
164. Selkoe D. J., (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
165. Selkoe D. J., (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113.
166. Shamir A., Kwon O. B., Karavanova I., Vullhorst D., Leiva-Salcedo E., Janssen M. J., and, Buonanno A., (2012) The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J. Neurosci. 32, 2988-2997.
167. Shipton O. A., Leitz J. R., Dworzak J., et al,. (2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J. Neurosci. 31, 1688-1692.
168. Silberberg G., Darvasi A., Pinkas-Kramarski R., and, Navon R., (2006) The involvement of ErbB4 with schizophrenia: association and expression studies. American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of. Psychiatr. Genet. 141B, 142-148.
169. Spencer K. M., (2009) The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modeling. Front. Hum. Neurosci. 3, 33.
170. Spencer K. M., Nestor P. G., Perlmutter R., Niznikiewicz M. A., Klump M. C., Frumin M., Shenton M. E., and, McCarley R. W., (2004) Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl Acad. Sci. USA 101, 17288-17293.
171. Spires-Jones T. L., Meyer-Luehmann M., Osetek J. D., Jones P. B., Stern E. A., Bacskai B. J., and, Hyman B. T., (2007) Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am. J. Pathol. 171, 1304-1311.
172. van Spronsen M., and, Hoogenraad C. C., (2010) Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 10, 207-214.
173. Stark K. L., Xu B., Bagchi A., et al,. (2008) Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760.
174. Starkstein S. E., Vazquez S., Petracca G., Sabe L., Migliorelli R., Teson A., and, Leiguarda R., (1994) A SPECT study of delusions in Alzheimer's disease. Neurology 44, 2055-2059.
175. Steen R. G., Mull C., McClure R., Hamer R. M., and, Lieberman J. A., (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510-518.
176. Stefansson H., Sigurdsson E., Steinthorsdottir V., et al,. (2002) Neuregulin 1 and Susceptibility to Schizophrenia. Am. J. Hum. Genet. 71.
177. Stefansson H., Thorgeirsson T. E., Gulcher J. R., and, Stefansson K., (2003) Neuregulin 1 in schizophrenia: out of Iceland. Mol. Psychiatry 8, 639-640.
178. Steiner H., Blum M., Kitai S. T., and, Fedi P., (1999) Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp. Neurol. 159, 494-503.
179. Sultzer D. L., Brown C. V., Mandelkern M. A., Mahler M. E., Mendez M. F., Chen S. T., and, Cummings J. L., (2003) Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am. J. Psychiatry 160, 341-349.
180. Sweet R. A., Nimgaonkar V. L., Devlin B., Lopez O. L., and, DeKosky S. T., (2002a) Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 58, 907-911.
181. Sweet R. A., Panchalingam K., Pettegrew J. W., McClure R. J., Hamilton R. L., Lopez O. L., Kaufer D. I., DeKosky S. T., and, Klunk W. E., (2002b) Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol. Aging 23, 547-553.
182. Sweet R. A., Henteleff R. A., Zhang W., Sampson A. R., and, Lewis D. A., (2009) Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 34, 374-389.
183. Sweet R. A., Bennett D. A., Graff-Radford N. R., and, Mayeux R., (2010) Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain 133, 1155-1162.
184. Sweet R. A., Seltman H., Emanuel J. E., Lopez O. L., Becker J. T., Bis J. C., Weamer E. A., DeMichele-Sweet M. A., and, Kuller L. H., (2012) Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. Am. J. Psychiatry 169, 954-962.
185. Tada T., and, Sheng M., (2006) Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 16, 95-101.
186. Tan W., Dean M., and, Law A. J., (2010) Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain. PLoS ONE 5, e12924.
187. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., and, Katzman R., (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
188. Thompson M., Lauderdale S., Webster M. J., Chong V. Z., McClintock B., Saunders R., and, Weickert C. S., (2007) Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res. 1139, 95-109.
189. Tukker J. J., Fuentealba P., Hartwich K., Somogyi P., and, Klausberger T., (2007) Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo. J. Neurosci. 27, 8184-8189.
190. Valnegri P., Khelfaoui M., Dorseuil O., et al,. (2011a) A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbα. Nat. Neurosci. 14, 1293-1301.
191. Valnegri P., Montrasio C., Brambilla D., Ko J. W., Passafaro M., and, Sala C., (2011b) The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2. Hum. Mol. Genet. 20, 4797-4809.
192. Verpelli C., Dvoretskova E., Vicidomini C., et al,. (2011) Importance of shank3 in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J. Biol. Chem. 286, 34839-34850.
193. Vullhorst D., Neddens J., Karavanova I., Tricoire L., Petralia R. S., McBain C. J., and, Buonanno A., (2009) Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 29, 12255-12264.
194. Walsh D. M., and, Selkoe D. J., (2007) A beta oligomers-a decade of discovery. J. Neurochem. 101, 1172-1184.
195. Walss-Bass C., Liu W., Lew D. F., Villegas R., Montero P., Dassori A., Leach R. J., Almasy L., Escamilla M., and, Raventos H., (2006) A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol. Psychiatry 60, 548-553.
196. Wang X., McCoy P. A., Rodriguiz R. M., et al,. (2011) Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20, 3093-3108.
197. Weickert C. S., Tiwari Y., Schofield P. R., Mowry B. J., and, Fullerton J. M., (2012) Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl. Psychiatry 2, e104.
198. Weissflog L., Scholz C. J., Jacob C. P., et al,. (2012) KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur. Neuropsychopharmacol. S0924-977X, 00214-3.
199. Wen L., Lu Y. S., Zhu X. H., et al,. (2010) Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl Acad. Sci. USA 107, 1211-1216.
200. Wilson H. L., Wong A. C., Shaw S. R., Tse W. Y., Stapleton G. A., Phelan M. C., Hu S., Marshall J., and, McDermid H. E., (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575-584.
201. Wilson T. W., Hernandez O. O., Asherin R. M., Teale P. D., Reite M. L., and, Rojas D. C., (2008) Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis. Cereb. Cortex 18, 371-378.
202. Winterer G., and, Weinberger D. R., (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27, 683-690.
203. Wöhr M., Roullet F. I., Hung A. Y., Sheng M., and, Crawley J. N., (2011) Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS ONE 6, e20631.
204. Won H., Lee H. R., Gee H. Y., et al,. (2012) Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261-265.
205. Woo T. U., Whitehead R. E., Melchitzky D. S., and, Lewis D. A., (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl Acad. Sci. USA 95, 5341-5346.
206. Woo T. U., Walsh J. P., and, Benes F. M., (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649-657.
207. Xie Z., Srivastava D. P., Photowala H., Kai L., Cahill M. E., Woolfrey K. M., Shum C. Y., Surmeier D. J., and, Penzes P., (2007) Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 56, 640-656.
208. Xie Z., Cahill M. E., and, Penzes P., (2010) Kalirin loss results in cortical morphological alterations. Mol. Cell. Neurosci. 43, 81-89.
209. Yau H. J., Wang H. F., Lai C., and, Liu F. C., (2003) Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13, 252-264.
210. Yip J., Soghomonian J. J., and, Blatt G. J., (2007) Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 113, 559-568.
211. Yizhar O., Fenno L. E., Prigge M., et al,. (2011) Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171-178.
212. Yoshida T., Yasumura M., Uemura T., Lee S. J., Ra M., Taguchi R., Iwakura Y., and, Mishina M., (2011) IL-1 Receptor Accessory Protein-Like 1 Associated with Mental Retardation and Autism Mediates Synapse Formation by Trans-Synaptic Interaction with Protein Tyrosine Phosphatase {delta}. J. Neurosci. 31, 13485-13499.
213. Yu F. H., Mantegazza M., Westenbroek R. E., Robbins C. A., Kalume F., Burton K. A., Spain W. J., McKnight G. S., Scheuer T., and, Catterall W. A., (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 1142-1149.
214. Zemni R., Bienvenu T., Vinet M. C., et al,. (2000) A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet. 24, 167-170.
215. Zempel H., Thies E., Mandelkow E., and, Mandelkow E. M., (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950.
216. Zhao L., Ma Q. L., Calon F., et al,. (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234-242.
217. Zuo Y., Lin A., Chang P., and, Gan W. B., (2005) Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 46, 181-189.